Adient (NYSE:ADNT - Get Free Report) was upgraded by investment analysts at StockNews.com from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Tuesday.
A number of other brokerages also recently issued reports on ADNT. Morgan Stanley cut their target price on Adient from $21.00 to $19.00 and set an "underweight" rating for the company in a research note on Thursday, November 14th. Wells Fargo & Company downgraded Adient from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $27.00 to $20.00 in a report on Monday, December 16th. Bank of America lowered shares of Adient from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $30.00 to $24.00 in a research report on Thursday, November 21st. UBS Group boosted their price objective on shares of Adient from $19.00 to $20.00 and gave the stock a "neutral" rating in a report on Wednesday, January 29th. Finally, Barclays lowered their target price on shares of Adient from $24.00 to $21.00 and set an "equal weight" rating on the stock in a research report on Wednesday, January 22nd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $21.88.
Check Out Our Latest Report on ADNT
Adient Stock Performance
ADNT traded down $0.12 on Tuesday, hitting $15.83. 1,327,375 shares of the company traded hands, compared to its average volume of 1,249,435. Adient has a 12-month low of $15.57 and a 12-month high of $35.94. The company has a 50 day moving average of $17.13 and a 200-day moving average of $19.55. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $1.33 billion, a PE ratio of 791.25, a PEG ratio of 0.34 and a beta of 2.18.
Adient (NYSE:ADNT - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same period last year, the company earned $0.31 EPS. Sell-side analysts anticipate that Adient will post 1.76 earnings per share for the current year.
Insider Buying and Selling
In other Adient news, EVP James Conklin sold 11,500 shares of the business's stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $20.25, for a total transaction of $232,875.00. Following the completion of the sale, the executive vice president now owns 51,829 shares of the company's stock, valued at approximately $1,049,537.25. The trade was a 18.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.72% of the stock is owned by company insiders.
Hedge Funds Weigh In On Adient
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Hong Kong Ltd acquired a new position in shares of Adient during the fourth quarter worth $25,000. Versant Capital Management Inc increased its position in shares of Adient by 10,316.7% in the 4th quarter. Versant Capital Management Inc now owns 1,875 shares of the company's stock worth $32,000 after purchasing an additional 1,857 shares during the last quarter. R Squared Ltd acquired a new stake in Adient during the fourth quarter valued at approximately $32,000. IFP Advisors Inc lifted its stake in Adient by 6,924.2% during the fourth quarter. IFP Advisors Inc now owns 2,318 shares of the company's stock worth $40,000 after purchasing an additional 2,285 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company's stock valued at $42,000 after buying an additional 1,588 shares during the period. Hedge funds and other institutional investors own 92.44% of the company's stock.
About Adient
(
Get Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Recommended Stories

Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.